vTv Therapeutics VTVT
NASDAQ VTVT
$33.35 -0.12 (-0.36%)
At close: Sep 4, 2026 · 4:00 PM EDT

vTv Therapeutics (VTVT) Long-Term Debt Repayments (2015 - 2016)

vTv Therapeutics' (VTVT) quarterly Long-Term Debt Repayments came in at $4000.0 in Q4 2016, down 20.0% quarter-over-quarter from $5000.0 in Q3 2016.

Analysis

vTv Therapeutics (VTVT) Long-Term Debt Repayments (2015 - 2016) Analysis & Trends

vTv Therapeutics has disclosed Long-Term Debt Repayments across 2 years of filings, most recently posting $4000.0 for Q4 2016.

  • In Q4 2016, Long-Term Debt Repayments changed N/A year-over-year to $4000.0; the TTM figure through Dec 2016 stood at $22000.0 (changed N/A YoY), while the FY2016 annual figure was $33000.0, down 62.92% from the prior year.
  • Long-Term Debt Repayments came in at $4000.0 for Q4 2016 at vTv Therapeutics, down from $5000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $13000.0 in Q3 2015 to a low of $4000.0 in Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn -
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 2.00 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn 17.05 Mn
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -
10 vTv Therapeutics 413.85 Mn 413.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 4,000.00
Sep 30, 2016 5,000.00
Sep 30, 2015 13,000.00